<SEC-DOCUMENT>0001728117-21-000015.txt : 20210225
<SEC-HEADER>0001728117-21-000015.hdr.sgml : 20210225
<ACCEPTANCE-DATETIME>20210225080041
ACCESSION NUMBER:		0001728117-21-000015
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20210225
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210225
DATE AS OF CHANGE:		20210225

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Gossamer Bio, Inc.
		CENTRAL INDEX KEY:			0001728117
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				475461709
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38796
		FILM NUMBER:		21676465

	BUSINESS ADDRESS:	
		STREET 1:		3013 SCIENCE PARK
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		(858) 922-0718

	MAIL ADDRESS:	
		STREET 1:		3013 SCIENCE PARK
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>goss-20210225.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:d1d25b63-39fb-4304-9606-42f47eb493af,g:2bd1b8b7-33c5-40fd-b950-0d168af3e84e,d:cba57e36358b4ffa8210e333d4d10a6a--><html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>goss-20210225</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV80L2ZyYWc6ZWNkOTBiMWIxZWY1NDc5YmE5MjA1OTlkZDY3MDkwMWMvdGFibGU6NmM1ZGFhN2YzMjEzNGQzYzliYjMxZThjOGQ0YTdlOTAvdGFibGVyYW5nZTo2YzVkYWE3ZjMyMTM0ZDNjOWJiMzFlOGM4ZDRhN2U5MF8wLTEtMS0xLTA_6be3080a-c37a-45f7-ba4c-656928bf3a4c">0001728117</ix:nonNumeric><ix:nonNumeric contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109" format="ixt:booleanfalse" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV80L2ZyYWc6ZWNkOTBiMWIxZWY1NDc5YmE5MjA1OTlkZDY3MDkwMWMvdGFibGU6NmM1ZGFhN2YzMjEzNGQzYzliYjMxZThjOGQ0YTdlOTAvdGFibGVyYW5nZTo2YzVkYWE3ZjMyMTM0ZDNjOWJiMzFlOGM4ZDRhN2U5MF8xLTEtMS0xLTA_80e1610b-42dd-4555-97d7-e75091c9bcfd">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="goss-20210225.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001728117</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-09</xbrli:startDate><xbrli:endDate>2020-11-09</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="icba57e36358b4ffa8210e333d4d10a6a_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.040%"><tr><td style="width:1.0%"></td><td style="width:22.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.843%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.796%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGV4dHJlZ2lvbjo3M2QxN2JkODFiMzY0ODA2YmIzMDMzNGNmODFmODNkN18yNTky_a6e35883-67cf-496f-92ff-de91403b973b">8-K</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.040%"><tr><td style="width:1.0%"></td><td style="width:22.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.843%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.796%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGV4dHJlZ2lvbjo3M2QxN2JkODFiMzY0ODA2YmIzMDMzNGNmODFmODNkN18yMzE_1590e99a-b1f5-4e9b-a29f-02f4f1e21930">February 25, 2021</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.040%"><tr><td style="width:1.0%"></td><td style="width:22.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.843%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.796%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGV4dHJlZ2lvbjo3M2QxN2JkODFiMzY0ODA2YmIzMDMzNGNmODFmODNkN18yNTkz_2dd23a06-90ad-4f33-a6ad-ac5dae04df9a">GOSSAMER BIO, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Exact name of Registrant as Specified in Its Charter)</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.040%"><tr><td style="width:1.0%"></td><td style="width:22.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.843%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.796%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:32.135%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.283%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGFibGU6MGVjNmU2MjhjNzU2NDM2NmI4ZGFlMDRkOTIwZGU5ZTUvdGFibGVyYW5nZTowZWM2ZTYyOGM3NTY0MzY2YjhkYWUwNGQ5MjBkZTllNV8wLTAtMS0xLTA_8ac405bb-8c8b-40f7-826b-3163b14f0a20">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGFibGU6MGVjNmU2MjhjNzU2NDM2NmI4ZGFlMDRkOTIwZGU5ZTUvdGFibGVyYW5nZTowZWM2ZTYyOGM3NTY0MzY2YjhkYWUwNGQ5MjBkZTllNV8wLTEtMS0xLTA_27716830-b7db-43ba-8ad4-9ef331797b06">001-38796</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGFibGU6MGVjNmU2MjhjNzU2NDM2NmI4ZGFlMDRkOTIwZGU5ZTUvdGFibGVyYW5nZTowZWM2ZTYyOGM3NTY0MzY2YjhkYWUwNGQ5MjBkZTllNV8wLTItMS0xLTA_8d2bc8c4-039d-4de0-ab32-69b9e3844a9e">47-5461709</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or Other Jurisdiction<br/>of Incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(IRS Employer<br/>Identification No.)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGV4dHJlZ2lvbjo3M2QxN2JkODFiMzY0ODA2YmIzMDMzNGNmODFmODNkN18yNTk0_c6688f21-4f71-456b-8e9b-1231b27e627c">3013 Science Park Road</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGV4dHJlZ2lvbjo3M2QxN2JkODFiMzY0ODA2YmIzMDMzNGNmODFmODNkN18yNTk1_6dad76ca-301a-46fc-b96c-91c19c4a9ddf">San Diego</ix:nonNumeric>, <ix:nonNumeric contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGV4dHJlZ2lvbjo3M2QxN2JkODFiMzY0ODA2YmIzMDMzNGNmODFmODNkN18yNTk2_551b86f5-137b-4a6e-81e6-c4de3f14a7cc">California</ix:nonNumeric>, <ix:nonNumeric contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGV4dHJlZ2lvbjo3M2QxN2JkODFiMzY0ODA2YmIzMDMzNGNmODFmODNkN18zNjc_a368ee1e-1d10-4431-b2bb-71e26d09195d">92121</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of Principal Executive Offices) (Zip Code)</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGV4dHJlZ2lvbjo3M2QxN2JkODFiMzY0ODA2YmIzMDMzNGNmODFmODNkN180MjQ_65cfb322-9659-42d4-ba36-2e85984c3c26">858</ix:nonNumeric>) <ix:nonNumeric contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGV4dHJlZ2lvbjo3M2QxN2JkODFiMzY0ODA2YmIzMDMzNGNmODFmODNkN18yNTk3_f8055cb1-8951-4350-af60-3960aaf530fc">684-1300</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s Telephone Number, Including Area Code)</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">N/A</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former Name or Former Address, if Changed Since Last Report)</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.040%"><tr><td style="width:1.0%"></td><td style="width:22.843%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.843%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.796%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.468%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGFibGU6ZThiZTNlNmFkMmIyNDE5MGI0M2I0NDkyNWI4NDkzYTgvdGFibGVyYW5nZTplOGJlM2U2YWQyYjI0MTkwYjQzYjQ0OTI1Yjg0OTNhOF8wLTAtMS0xLTA_baf205f5-564d-4bd6-ab87-bfe2f5197fae">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.468%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGFibGU6ZTU4ZjQxNjMzMjc4NDUxM2E0NTljYjNkYmFiYzMyYjEvdGFibGVyYW5nZTplNThmNDE2MzMyNzg0NTEzYTQ1OWNiM2RiYWJjMzJiMV8wLTAtMS0xLTA_b299a7da-6f03-4a09-81c2-123df30f5ea3">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.468%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGFibGU6ZmIzYTFkNjlhNDkxNDJkM2E5MzA0MDYwMjZiZjRkOTAvdGFibGVyYW5nZTpmYjNhMWQ2OWE0OTE0MmQzYTkzMDQwNjAyNmJmNGQ5MF8wLTAtMS0xLTA_58f17006-d14c-4650-bd4c-7eeed0013b34">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.468%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGFibGU6YTYwYWYzNmE1MTAxNDRiNGIwYWNlZDFjZjFiMDMwNDcvdGFibGVyYW5nZTphNjBhZjM2YTUxMDE0NGI0YjBhY2VkMWNmMWIwMzA0N18wLTAtMS0xLTA_bdb997e9-fe8d-4922-b2e2-bfdba406f444">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.345%"><tr><td style="width:1.0%"></td><td style="width:36.532%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.862%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.681%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.862%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.363%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading<br/>Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGFibGU6N2RlYTZjN2YzODhjNGFkOWI2YzdiOTRiMGE4OTFhMGMvdGFibGVyYW5nZTo3ZGVhNmM3ZjM4OGM0YWQ5YjZjN2I5NGIwYTg5MWEwY18xLTAtMS0xLTA_cfedc274-19c0-45fd-a875-695b24902bfe">Common Stock, $0.0001 par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGFibGU6N2RlYTZjN2YzODhjNGFkOWI2YzdiOTRiMGE4OTFhMGMvdGFibGVyYW5nZTo3ZGVhNmM3ZjM4OGM0YWQ5YjZjN2I5NGIwYTg5MWEwY18xLTItMS0xLTA_a2eba317-c749-4fae-b1a2-c64dd2e7e7c9">GOSS</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGFibGU6N2RlYTZjN2YzODhjNGFkOWI2YzdiOTRiMGE4OTFhMGMvdGFibGVyYW5nZTo3ZGVhNmM3ZjM4OGM0YWQ5YjZjN2I5NGIwYTg5MWEwY18xLTQtMS0xLTA_056ad015-57e8-41b3-a6cb-8e1a632e7c18">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGV4dHJlZ2lvbjo3M2QxN2JkODFiMzY0ODA2YmIzMDMzNGNmODFmODNkN18yNTk4_bdc5eaa1-35e1-4e93-b283-738a44213cf9">&#9744;</ix:nonNumeric></span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.02 Results of Operations and Financial Condition.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 25, 2021, Gossamer Bio, Inc. (the &#8220;Company&#8221;) issued a press release reporting its financial results for the quarter and fiscal year ended December 31, 2020.&#160;The full text of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with General Instruction B.2 of Form 8-K, the information contained or incorporated herein, including the press release attached as Exhibit&#160;99.1, shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), or the Exchange Act, whether made before or after the date hereof, except as&#160;expressly set forth by specific reference in such filing to this Current Report on Form 8-K.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01 Financial Statements and Exhibits.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Exhibits.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.644%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="goss-20210225xexx991.htm">Press Release dated February 25, 2021</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:43.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.585%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.410%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GOSSAMER BIO, INC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: February 25, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Bryan Giraudo</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bryan Giraudo</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>goss-20210225xexx991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i3020c37496b546c1a8af9a70ad2f5b01_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div></div><div style="margin-top:10pt"><img alt="gossamer1.jpg" src="gossamer1.jpg" style="height:64px;margin-bottom:5pt;vertical-align:text-bottom;width:151px"></div><div style="margin-bottom:0.08pt;text-align:center"><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:700;line-height:125%">Gossamer Bio Announces Fourth Quarter and Full-Year 2020 Financial Results and Provides Business Update</font></div><div style="margin-top:10pt;text-align:center"><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">- Seralutinib (GB002) and GB004 continue to progress through ongoing Phase 2 TORREY and SHIFT-UC clinical trials for Pulmonary Arterial Hypertension (PAH) and Ulcerative Colitis (UC), respectively -</font></div><div style="margin-top:10pt;text-align:center"><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">- Topline results for both ongoing Phase 2 trials expected in the first half of 2022, subject to developments in the ongoing COVID-19 pandemic -</font></div><div style="margin-top:10pt;text-align:center"><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">- Gossamer to conduct no further clinical development of GB001 or related backup molecule without a partner -</font></div><div style="margin-top:10pt;text-align:center"><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">- Cash, cash equivalents and marketable securities totaled $513 million at year-end 2020 -</font></div><div style="margin-top:10pt"><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">SAN DIEGO&#8212;(BUSINESS WIRE)&#8212; February 25, 2020&#8212;Gossamer Bio, Inc. (Nasdaq&#58; GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced its financial results for the fourth quarter and year ended December 31, 2020 and provided a business update.</font></div><div style="margin-top:10pt"><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;The Gossamer team enters 2021 excited and focused on clinical trial execution,&#8221; said Faheem Hasnain, Co-Founder, Chairman and Chief Executive Officer of Gossamer. &#8220;Both seralutinib and GB004 are potentially paradigm shifting product candidates in indications of significant unmet patient need, and I am very proud of our team&#8217;s ongoing efforts to conduct our Phase 2 proof-of-concept studies for these programs despite the challenges of the pandemic.&#8221; </font></div><div style="margin-top:10pt"><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Clinical-Stage Product Candidate Updates</font></div><div style="margin-top:10pt"><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Seralutinib (GB002)&#58; Inhaled PDGFR, CSF1R and c-KIT Inhibitor for PAH</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:13.8pt">Enrollment ongoing in the TORREY Study, a Phase 2 clinical trial in patients with PAH whose disease has progressed despite standard-of-care therapy. The primary endpoint is change in pulmonary vascular resistance (PVR) from baseline at week 24. Topline data from the TORREY study are expected in the first half of 2022, subject to developments in the ongoing COVID-19 pandemic.</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:13.8pt">Key opinion leader-led webcast and presentation regarding PAH and seralutinib (GB002) held on December 15, 2020 available </font><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">through the &#8220;Events &#47; Presentations&#8221; page in the &#8220;Investors&#8221; section of the Company's website at </font><font style="background-color:#ffffff;color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">www.gossamerbio.com</font><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:10pt"><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GB004&#58; Oral HIF-1&#945; Stabilizer for Inflammatory Bowel Disease (IBD)</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:13.8pt">Enrollment ongoing in the SHIFT-UC Study, a Phase 2 clinical trial in patients with active UC despite treatment with 5-ASAs. The primary endpoint is proportion of patients with clinical </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:10pt;padding-left:36pt"><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">remission at week 12. Topline data from the SHIFT-UC study are expected in the first half of 2022, subject to developments in the ongoing COVID-19 pandemic. </font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:13.8pt">Key opinion leader-led webcast and presentation regarding IBD and GB004 held on February 18, 2021 available </font><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:12pt;font-weight:400;line-height:120%">through the &#8220;Events &#47; Presentations&#8221; page in the &#8220;Investors&#8221; section of the Company's website at </font><font style="background-color:#ffffff;color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">www.gossamerbio.com</font><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:10pt"><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GB1275&#58; Oral CD11b Modulator for Oncology Indications</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:13.8pt">Enrollment ongoing in a Phase 1 expansion cohort studying the recommended Phase 2 dose in KEYNOTE-A36, a Phase 1&#47;2 clinical trial, including patients with gastric or esophageal cancer who have progressed after initial response to anti-PD-1 therapy and patients with advanced MSS colorectal cancer. Further Phase 1 data expected from this study in 2021. </font></div><div style="margin-top:10pt"><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GB001&#58; Oral DP2 Antagonist for Eosinophilic Asthma</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:13.8pt">Gossamer engaged with the FDA and the EMA about the clinical development path in asthma, and based off those interactions, Gossamer believes that there is a viable clinical development path for GB001, or its backup molecule, in asthma. Gossamer does not currently plan to move forward with GB001, or its backup molecule, in further clinical trials without a partner. </font></div><div style="margin-top:10pt"><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Financial Results for Quarter and Full Year Ended December 31, 2020</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:12.53pt">Cash, Cash Equivalents and Marketable Securities</font><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; Cash, cash equivalents and marketable securities as of December 31, 2020, were $512.6 million. As a result, we currently expect cash, cash equivalents and marketable securities, and access to our debt facility will be sufficient to fund operating and capital expenditures into the second half of 2023.</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:13.13pt">Research and Development (R&#38;D) Expenses</font><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; For the quarter ended December 31, 2020, R&#38;D expenses were $38.9 million compared to R&#38;D expenses of $42.6 million for the same period in 2019. R&#38;D expenses for the full year ended December 31, 2020, were $160.9 million compared to $143.4 million for the full year ended December 31, 2019. The increases were primarily due to an increase in expenses for GB004, seralutinib, GB1275 and preclinical programs.</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:12.53pt">In-Process Research and Development (IPR&#38;D) Expenses</font><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; For the quarter ended December 31, 2020, IPR&#38;D expenses were $5.3 million compared to $1.6 million for the same period in 2019. IPR&#38;D expenses for the full year ended December 31, 2020, were $23.4 million compared to $3.6 million for the full year ended December 31, 2019. The increases were primarily attributable to a $15.0 million payment to Aerpio in connection with the amendment to the in-license agreement of GB004 in 2020 and a milestone payment of $5.0 million in connection with the initiation of the first Phase 2 clinical trial of seralutinib in 2020.</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:12.53pt">General and Administrative (G&#38;A) Expenses</font><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; For the quarter ended December 31, 2020, G&#38;A expenses were $15.9 million compared to $11.6 million for the same period in 2019. G&#38;A expenses for the full year ended December 31, 2020, were $49.7 million compared to $39.1 million for the full year ended December 31, 2019. The increases were primarily </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:10pt;padding-left:36pt"><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">attributable to an increase in stock-based compensation costs and an increase in personnel-related costs.</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8226;</font><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:12.53pt">Net Loss</font><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58; Net loss for the three months ended December 31, 2020, was $64.6 million, or $0.88 per share, compared to a net loss of $54.7 million, or $0.89 per share, for the same period in 2019. Net loss for the full year ended December 31, 2020, was $243.4 million, or $3.55 per share compared to a net loss of $180.3 million, or $3.29 per share, for the full year ended December 31, 2019.</font></div><div style="margin-top:10pt"><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Conference Call and Webcast</font></div><div style="margin-top:10pt"><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Gossamer&#8217;s management team will host a conference call and live audio webcast at 8&#58;30 a.m. ET today, Thursday, February 25, to discuss its fourth quarter and full year 2020 financial results and provide a corporate update.</font></div><div style="margin-top:10pt"><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The live audio webcast may be accessed through the &#8220;Events &#47; Presentations&#8221; page in the &#8220;Investors&#8221; section of the Company's website at </font><font style="background-color:#ffffff;color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">www.gossamerbio.com</font><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Alternatively, the conference call may be accessed through the following&#58;</font></div><div style="margin-top:10pt"><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Conference ID&#58; 5764004</font></div><div><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Domestic Dial-in Number&#58; (833) 646-0603</font></div><div><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">International Dial-in Number&#58; (929) 517-9782</font></div><div><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Live Webcast&#58; </font><font style="background-color:#ffffff;color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">https&#58;&#47;&#47;edge.media-server.com&#47;mmc&#47;p&#47;vsbk8uqe</font><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="margin-top:10pt"><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">A replay of the audio webcast will be available for 30 days on the &#8220;Investors&#8221; section of the Company's website, </font><font style="background-color:#ffffff;color:#0000ff;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">www.gossamerbio.com</font><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-top:10pt"><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">About&#160;Gossamer Bio</font></div><div style="margin-top:10pt"><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Gossamer Bio&#160;is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology. Its goal is to be an industry leader in each of these therapeutic areas and to enhance and extend the lives of patients suffering from such diseases.</font></div><div style="margin-top:10pt"><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Forward-Looking Statements</font></div><div style="margin-top:10pt"><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Gossamer cautions you that statements contained in this press release regarding matters that are not historical facts are forward-looking statements. These statements are based on the Company&#8217;s current beliefs and expectations. Such forward-looking statements include, but are not limited to, statements regarding&#58; the anticipated timing of enrollment of clinical trials for our product candidates&#59; plans to advance our product candidates&#59; expectations on the timing of data readouts from our clinical studies&#59; the potential clinical benefits, safety profile and market potential of our product candidates&#59; the potential of our product candidates to benefit high unmet need patient populations&#59; the expected impact of COVID-19&#59; and the expected timeframe for funding our operating plan with current cash, cash equivalents and marketable securities. The inclusion of forward-looking statements should not be regarded as a representation by Gossamer that any of its plans will be achieved. Actual results may differ from those set forth in this press release due to the risks and uncertainties inherent in Gossamer&#8217;s business, including, without limitation&#58; potential delays in the commencement, enrollment and completion of clinical trials&#59; disruption to our operations from the recent global outbreak of the COVID-19 pandemic, including clinical trial delays&#59; the Company&#8217;s dependence on third parties in connection with product manufacturing, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:10pt"><font style="color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">research and preclinical and clinical testing&#59; the results of preclinical studies and early clinical trials are not necessarily predictive of future results&#59; the success of Gossamer&#8217;s clinical trials and preclinical studies for its product candidates&#59; interim results do not necessarily predict final results and one or more of the outcomes may materially change as the trial continues and more patient data become available and following more comprehensive audit and verification procedures&#59; regulatory developments in the United States and foreign countries&#59; unexpected adverse side effects or inadequate efficacy of our product candidates that may limit their development, regulatory approval and&#47;or commercialization, or may result in recalls or product liability claims&#59; Gossamer&#8217;s ability to obtain and maintain intellectual property protection for its product candidates&#59; Gossamer&#8217;s ability to comply with its obligations in collaboration agreements with third parties or the agreements under which it licenses intellectual property rights from third parties&#59; Gossamer may use its capital resources sooner than it expects&#59; and other risks described in the Company&#8217;s prior press releases and the Company&#8217;s filings with the Securities and Exchange Commission (SEC), including under the heading &#8220;Risk Factors&#8221; in the Company&#8217;s annual report on Form 10-K and any subsequent filings with the SEC. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and Gossamer undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, which is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GOSSAMER BIO, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">CONDENSED CONSOLIDATED FINANCIAL STATEMENT DATA</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(UNAUDITED&#59; IN THOUSANDS, EXCEPT SHARE AND PER SHARE DATA) </font></div><div style="margin-top:10pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.008%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.521%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.521%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.521%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.526%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Three months ended December 31,</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year ended December 31,</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">STATEMENTS OF OPERATIONS DATA&#58;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating expenses&#58;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</font></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,910&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42,596&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">160,854&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">143,403&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In process research and development</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,300&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,600&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23,380&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,600&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15,877&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11,591&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49,728&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39,136&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60,087&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55,787&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">233,962&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">186,139&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Loss from operations</font></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(60,087)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(55,787)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(233,962)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(186,139)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense)</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">366&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,567&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,442&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,563&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,753)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(715)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12,666)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1,938)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense)</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(130)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">237&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(174)</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,207&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other income (expense), net</font></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4,517)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,089&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9,398)</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,832&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Net loss</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(64,604)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(54,698)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(243,360)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">$</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(180,307)</font></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net loss per share, basic and diluted</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.88)</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.89)</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3.55)</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3.29)</font></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average common shares outstanding, basic and diluted</font></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73,212,186&#160;</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61,282,084&#160;</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68,510,260&#160;</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54,740,170&#160;</font></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:10pt;text-align:center"><font><br></font></div><div style="margin-bottom:8pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.008%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.011%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:125%">BALANCE SHEET DATA&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2020</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2019</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash, cash equivalents, and marketable securities</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">512,628&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">401,766&#160;</font></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Working capital</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">483,672&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">372,394&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">539,433&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">426,604&#160;</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total liabilities</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">218,749&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74,119&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated deficit</font></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(577,530)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(334,170)</font></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Total stockholders' equity</font></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">320,684&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">352,485&#160;</font></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-top:10pt"><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:700;line-height:120%">For Investors and Media&#58; </font></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Bryan Giraudo, Chief Financial Officer</font></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Gossamer Bio Investor Relations</font></div><div style="margin-bottom:0.08pt"><font style="background-color:#ffffff;color:#0a0a0a;font-family:'Cambria',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ir&#64;gossamerbio.com</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>goss-20210225.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:d1d25b63-39fb-4304-9606-42f47eb493af,g:2bd1b8b7-33c5-40fd-b950-0d168af3e84e-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:goss="http://www.gossamerbio.com/20210225" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.gossamerbio.com/20210225">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="goss-20210225_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="goss-20210225_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="goss-20210225_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="goss-20210225_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.gossamerbio.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>4
<FILENAME>goss-20210225_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:d1d25b63-39fb-4304-9606-42f47eb493af,g:2bd1b8b7-33c5-40fd-b950-0d168af3e84e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.gossamerbio.com/role/Cover" xlink:type="simple" xlink:href="goss-20210225.xsd#Cover"/>
  <link:calculationLink xlink:role="http://www.gossamerbio.com/role/Cover" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>goss-20210225_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:d1d25b63-39fb-4304-9606-42f47eb493af,g:2bd1b8b7-33c5-40fd-b950-0d168af3e84e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.gossamerbio.com/role/Cover" xlink:type="simple" xlink:href="goss-20210225.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.gossamerbio.com/role/Cover" xlink:type="extended" id="i338a1de83d704ec2bb863e3af18107f3_Cover"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>goss-20210225_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:d1d25b63-39fb-4304-9606-42f47eb493af,g:2bd1b8b7-33c5-40fd-b950-0d168af3e84e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_DocumentType_04935806-be3e-4908-9dca-98a4f1d263b4_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_b149deb9-bb16-4369-abd8-02c19749bf95_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_9147165f-d007-4a24-b747-9f21f839ff3a_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_fb72c89f-b1cc-4307-89f8-f557822806ea_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_1c06a78b-d35e-457a-89db-8b78f09b9e39_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_6e9c4bd7-34db-44f2-a246-8c2a78c04b56_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_1934412d-1258-4887-a6b7-c4b790a46d82_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_75dd1986-5a0d-4c34-bfb6-53cb91d0bf1b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_74798da0-d314-43c7-bb54-7eedefeff7d2_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_42048c1c-1b14-4211-aa59-22429874501a_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_caa35952-4d62-4b45-8448-0fc2cdef3de7_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_9e5c9017-3e5e-444b-8b0f-b89c4fb794d3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_bbec989d-52b7-4856-84c7-bcd343218124_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_f7d76eda-7641-434d-b977-63e7a7d7372d_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_fe786c72-bdf4-470d-8c42-abef87484a91_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_d1f4b2c5-3f02-4155-a96f-9f495568d6a4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_cc54c54a-a6a2-4f63-9a91-a8b71d84ec27_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_90a6fe35-e691-47ac-9906-8fb5d0aa9c0a_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_51e20dcb-3ac9-4478-980d-9cf5ab0e322a_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_b65e1c69-63fd-4861-892f-e35e5103286f_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_cea39e3e-477c-4f5a-8af5-e6ad721ed6a1_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_2d0a32c2-0867-4f7e-8592-52d533cb725b_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_7f228b4d-6b6b-4781-955b-6db85c5983b9_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>goss-20210225_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:d1d25b63-39fb-4304-9606-42f47eb493af,g:2bd1b8b7-33c5-40fd-b950-0d168af3e84e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.gossamerbio.com/role/Cover" xlink:type="simple" xlink:href="goss-20210225.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.gossamerbio.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_24e331d6-3bd8-4f66-bf8a-93172b2f62de" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_418da42f-5710-46bd-b6e6-8cfbfe3c7198" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24e331d6-3bd8-4f66-bf8a-93172b2f62de" xlink:to="loc_dei_DocumentType_418da42f-5710-46bd-b6e6-8cfbfe3c7198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_205bffe8-ad23-4deb-af5c-4d16844f41e4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24e331d6-3bd8-4f66-bf8a-93172b2f62de" xlink:to="loc_dei_DocumentPeriodEndDate_205bffe8-ad23-4deb-af5c-4d16844f41e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_6a8305e1-2ab0-43cc-a460-85705fe6a872" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24e331d6-3bd8-4f66-bf8a-93172b2f62de" xlink:to="loc_dei_EntityRegistrantName_6a8305e1-2ab0-43cc-a460-85705fe6a872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_e2ae623e-8c47-4b01-a8eb-d0b0d357c510" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24e331d6-3bd8-4f66-bf8a-93172b2f62de" xlink:to="loc_dei_EntityIncorporationStateCountryCode_e2ae623e-8c47-4b01-a8eb-d0b0d357c510" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_5326e6ba-2f8c-4056-a92c-da2a1c9fdb87" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24e331d6-3bd8-4f66-bf8a-93172b2f62de" xlink:to="loc_dei_EntityFileNumber_5326e6ba-2f8c-4056-a92c-da2a1c9fdb87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_276b304c-21b0-4f9c-94a0-b4ad55411059" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24e331d6-3bd8-4f66-bf8a-93172b2f62de" xlink:to="loc_dei_EntityTaxIdentificationNumber_276b304c-21b0-4f9c-94a0-b4ad55411059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_b09d5ede-ab16-49c9-8a84-7bf0e58e31fe" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24e331d6-3bd8-4f66-bf8a-93172b2f62de" xlink:to="loc_dei_EntityAddressAddressLine1_b09d5ede-ab16-49c9-8a84-7bf0e58e31fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_d907b7c6-7360-488a-83ba-0b16e765c383" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24e331d6-3bd8-4f66-bf8a-93172b2f62de" xlink:to="loc_dei_EntityAddressCityOrTown_d907b7c6-7360-488a-83ba-0b16e765c383" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_cafce980-02d2-4186-8447-8b24e86c4db9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24e331d6-3bd8-4f66-bf8a-93172b2f62de" xlink:to="loc_dei_EntityAddressStateOrProvince_cafce980-02d2-4186-8447-8b24e86c4db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_f05b4a6c-bb1c-4784-baa9-59f000ed8990" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24e331d6-3bd8-4f66-bf8a-93172b2f62de" xlink:to="loc_dei_EntityAddressPostalZipCode_f05b4a6c-bb1c-4784-baa9-59f000ed8990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_b87f992e-9aab-41f0-aa03-eaf97b7ac9cc" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24e331d6-3bd8-4f66-bf8a-93172b2f62de" xlink:to="loc_dei_CityAreaCode_b87f992e-9aab-41f0-aa03-eaf97b7ac9cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_4e4e6bce-47f7-4390-85ed-2a6bdd748d84" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24e331d6-3bd8-4f66-bf8a-93172b2f62de" xlink:to="loc_dei_LocalPhoneNumber_4e4e6bce-47f7-4390-85ed-2a6bdd748d84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_0f16c0b6-3a87-4e97-a13a-805af3fd758d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24e331d6-3bd8-4f66-bf8a-93172b2f62de" xlink:to="loc_dei_WrittenCommunications_0f16c0b6-3a87-4e97-a13a-805af3fd758d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_16b10036-b719-46b7-91c4-378d595c5243" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24e331d6-3bd8-4f66-bf8a-93172b2f62de" xlink:to="loc_dei_SolicitingMaterial_16b10036-b719-46b7-91c4-378d595c5243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_7ca33566-3f0c-4598-971c-71176edacb26" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24e331d6-3bd8-4f66-bf8a-93172b2f62de" xlink:to="loc_dei_PreCommencementTenderOffer_7ca33566-3f0c-4598-971c-71176edacb26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_3c323860-bdcf-4a1a-a89c-9390ee1ec6fa" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24e331d6-3bd8-4f66-bf8a-93172b2f62de" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_3c323860-bdcf-4a1a-a89c-9390ee1ec6fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_b8784ab6-4392-4416-88d6-5b02289184c3" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24e331d6-3bd8-4f66-bf8a-93172b2f62de" xlink:to="loc_dei_Security12bTitle_b8784ab6-4392-4416-88d6-5b02289184c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_8c3ca6f9-ca92-41d0-bbca-2c38ba1ea56b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24e331d6-3bd8-4f66-bf8a-93172b2f62de" xlink:to="loc_dei_TradingSymbol_8c3ca6f9-ca92-41d0-bbca-2c38ba1ea56b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_d8e7f6ea-d90b-40dd-b0bf-b953d4efc0c8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24e331d6-3bd8-4f66-bf8a-93172b2f62de" xlink:to="loc_dei_SecurityExchangeName_d8e7f6ea-d90b-40dd-b0bf-b953d4efc0c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_21a0dfee-aa13-4944-9d83-8ecbf28c0139" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24e331d6-3bd8-4f66-bf8a-93172b2f62de" xlink:to="loc_dei_EntityEmergingGrowthCompany_21a0dfee-aa13-4944-9d83-8ecbf28c0139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_7eb2c051-b27f-4730-b3b0-bc3f3993d609" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24e331d6-3bd8-4f66-bf8a-93172b2f62de" xlink:to="loc_dei_EntityExTransitionPeriod_7eb2c051-b27f-4730-b3b0-bc3f3993d609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_e23f2982-c69b-45e6-a3a4-905df59e5b5b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24e331d6-3bd8-4f66-bf8a-93172b2f62de" xlink:to="loc_dei_EntityCentralIndexKey_e23f2982-c69b-45e6-a3a4-905df59e5b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_65fb51a5-22a3-4bcb-af4e-1775d1bf5d46" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_24e331d6-3bd8-4f66-bf8a-93172b2f62de" xlink:to="loc_dei_AmendmentFlag_65fb51a5-22a3-4bcb-af4e-1775d1bf5d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>gossamer1.jpg
<TEXT>
begin 644 gossamer1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !( *H# 2(  A$! Q$!_\0
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M#^E$>K6<L,LJR'9$P1LJ<[B!\N.N><8ZYH O451;46B3S9K*YCAZER%.T>I
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>goss-20210225_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="goss-20210225.xsd" xlink:type="simple"/>
    <context id="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001728117</identifier>
        </entity>
        <period>
            <startDate>2020-11-09</startDate>
            <endDate>2020-11-09</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV80L2ZyYWc6ZWNkOTBiMWIxZWY1NDc5YmE5MjA1OTlkZDY3MDkwMWMvdGFibGU6NmM1ZGFhN2YzMjEzNGQzYzliYjMxZThjOGQ0YTdlOTAvdGFibGVyYW5nZTo2YzVkYWE3ZjMyMTM0ZDNjOWJiMzFlOGM4ZDRhN2U5MF8wLTEtMS0xLTA_6be3080a-c37a-45f7-ba4c-656928bf3a4c">0001728117</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV80L2ZyYWc6ZWNkOTBiMWIxZWY1NDc5YmE5MjA1OTlkZDY3MDkwMWMvdGFibGU6NmM1ZGFhN2YzMjEzNGQzYzliYjMxZThjOGQ0YTdlOTAvdGFibGVyYW5nZTo2YzVkYWE3ZjMyMTM0ZDNjOWJiMzFlOGM4ZDRhN2U5MF8xLTEtMS0xLTA_80e1610b-42dd-4555-97d7-e75091c9bcfd">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGV4dHJlZ2lvbjo3M2QxN2JkODFiMzY0ODA2YmIzMDMzNGNmODFmODNkN18yNTky_a6e35883-67cf-496f-92ff-de91403b973b">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGV4dHJlZ2lvbjo3M2QxN2JkODFiMzY0ODA2YmIzMDMzNGNmODFmODNkN18yMzE_1590e99a-b1f5-4e9b-a29f-02f4f1e21930">2021-02-25</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGV4dHJlZ2lvbjo3M2QxN2JkODFiMzY0ODA2YmIzMDMzNGNmODFmODNkN18yNTkz_2dd23a06-90ad-4f33-a6ad-ac5dae04df9a">GOSSAMER BIO, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGFibGU6MGVjNmU2MjhjNzU2NDM2NmI4ZGFlMDRkOTIwZGU5ZTUvdGFibGVyYW5nZTowZWM2ZTYyOGM3NTY0MzY2YjhkYWUwNGQ5MjBkZTllNV8wLTAtMS0xLTA_8ac405bb-8c8b-40f7-826b-3163b14f0a20">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGFibGU6MGVjNmU2MjhjNzU2NDM2NmI4ZGFlMDRkOTIwZGU5ZTUvdGFibGVyYW5nZTowZWM2ZTYyOGM3NTY0MzY2YjhkYWUwNGQ5MjBkZTllNV8wLTEtMS0xLTA_27716830-b7db-43ba-8ad4-9ef331797b06">001-38796</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGFibGU6MGVjNmU2MjhjNzU2NDM2NmI4ZGFlMDRkOTIwZGU5ZTUvdGFibGVyYW5nZTowZWM2ZTYyOGM3NTY0MzY2YjhkYWUwNGQ5MjBkZTllNV8wLTItMS0xLTA_8d2bc8c4-039d-4de0-ab32-69b9e3844a9e">47-5461709</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGV4dHJlZ2lvbjo3M2QxN2JkODFiMzY0ODA2YmIzMDMzNGNmODFmODNkN18yNTk0_c6688f21-4f71-456b-8e9b-1231b27e627c">3013 Science Park Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGV4dHJlZ2lvbjo3M2QxN2JkODFiMzY0ODA2YmIzMDMzNGNmODFmODNkN18yNTk1_6dad76ca-301a-46fc-b96c-91c19c4a9ddf">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGV4dHJlZ2lvbjo3M2QxN2JkODFiMzY0ODA2YmIzMDMzNGNmODFmODNkN18yNTk2_551b86f5-137b-4a6e-81e6-c4de3f14a7cc">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGV4dHJlZ2lvbjo3M2QxN2JkODFiMzY0ODA2YmIzMDMzNGNmODFmODNkN18zNjc_a368ee1e-1d10-4431-b2bb-71e26d09195d">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGV4dHJlZ2lvbjo3M2QxN2JkODFiMzY0ODA2YmIzMDMzNGNmODFmODNkN180MjQ_65cfb322-9659-42d4-ba36-2e85984c3c26">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGV4dHJlZ2lvbjo3M2QxN2JkODFiMzY0ODA2YmIzMDMzNGNmODFmODNkN18yNTk3_f8055cb1-8951-4350-af60-3960aaf530fc">684-1300</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGFibGU6ZThiZTNlNmFkMmIyNDE5MGI0M2I0NDkyNWI4NDkzYTgvdGFibGVyYW5nZTplOGJlM2U2YWQyYjI0MTkwYjQzYjQ0OTI1Yjg0OTNhOF8wLTAtMS0xLTA_baf205f5-564d-4bd6-ab87-bfe2f5197fae">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGFibGU6ZTU4ZjQxNjMzMjc4NDUxM2E0NTljYjNkYmFiYzMyYjEvdGFibGVyYW5nZTplNThmNDE2MzMyNzg0NTEzYTQ1OWNiM2RiYWJjMzJiMV8wLTAtMS0xLTA_b299a7da-6f03-4a09-81c2-123df30f5ea3">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGFibGU6ZmIzYTFkNjlhNDkxNDJkM2E5MzA0MDYwMjZiZjRkOTAvdGFibGVyYW5nZTpmYjNhMWQ2OWE0OTE0MmQzYTkzMDQwNjAyNmJmNGQ5MF8wLTAtMS0xLTA_58f17006-d14c-4650-bd4c-7eeed0013b34">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGFibGU6YTYwYWYzNmE1MTAxNDRiNGIwYWNlZDFjZjFiMDMwNDcvdGFibGVyYW5nZTphNjBhZjM2YTUxMDE0NGI0YjBhY2VkMWNmMWIwMzA0N18wLTAtMS0xLTA_bdb997e9-fe8d-4922-b2e2-bfdba406f444">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGFibGU6N2RlYTZjN2YzODhjNGFkOWI2YzdiOTRiMGE4OTFhMGMvdGFibGVyYW5nZTo3ZGVhNmM3ZjM4OGM0YWQ5YjZjN2I5NGIwYTg5MWEwY18xLTAtMS0xLTA_cfedc274-19c0-45fd-a875-695b24902bfe">Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGFibGU6N2RlYTZjN2YzODhjNGFkOWI2YzdiOTRiMGE4OTFhMGMvdGFibGVyYW5nZTo3ZGVhNmM3ZjM4OGM0YWQ5YjZjN2I5NGIwYTg5MWEwY18xLTItMS0xLTA_a2eba317-c749-4fae-b1a2-c64dd2e7e7c9">GOSS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGFibGU6N2RlYTZjN2YzODhjNGFkOWI2YzdiOTRiMGE4OTFhMGMvdGFibGVyYW5nZTo3ZGVhNmM3ZjM4OGM0YWQ5YjZjN2I5NGIwYTg5MWEwY18xLTQtMS0xLTA_056ad015-57e8-41b3-a6cb-8e1a632e7c18">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109"
      id="id3VybDovL2RvY3MudjEvZG9jOmNiYTU3ZTM2MzU4YjRmZmE4MjEwZTMzM2Q0ZDEwYTZhL3NlYzpjYmE1N2UzNjM1OGI0ZmZhODIxMGUzMzNkNGQxMGE2YV8xL2ZyYWc6NzNkMTdiZDgxYjM2NDgwNmJiMzAzMzRjZjgxZjgzZDcvdGV4dHJlZ2lvbjo3M2QxN2JkODFiMzY0ODA2YmIzMDMzNGNmODFmODNkN18yNTk4_bdc5eaa1-35e1-4e93-b283-738a44213cf9">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm139779637293592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Nov. 09, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb. 25,  2021<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">GOSSAMER BIO, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38796<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">47-5461709<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3013 Science Park Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">684-1300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GOSS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001728117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MI6J//X7W*+F?&^[_$L4/4$L#!!0    ( !1 65*7BKL<P    !,"   +
M7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_
MK]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?2
M0$3;8T.P6BP^0"X99K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-
MTG\R]_,,-47E2B.56QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z
M6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%     @ %$!94JK$(A8S 0
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M6N=6RKV'5[+E&''\GN4/4$L#!!0    ( !1 65(D'INBK0   /@!   :
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'.UD3T.@S ,A:\2Y0 U4*E#!4Q=
M6"LN$ 7S(Q(2Q:X*MR^% 9 Z=&&RGBU_[\E.GV@4=VZ@MO,D1FL&RF3+[.\
MI%NTBB[.XS!/:A>LXEF&!KS2O6H0DBBZ0=@S9)[NF:*<//Y#='7=:7PX_;(X
M\ \PO%WHJ45D*4H5&N1,PFBV-L%2XLM,EJ*H,AF**I9P6B#BR2!M:59]L$].
MM.=Y%S?W1:[-XPFNWPQP>'3^ 5!+ P04    "  40%E299!YDAD!  #/ P
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M<' N>&UL4$L! A0#%     @ %$!94L\8"(;O    *P(  !$
M ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ %$!94IE<G",0
M!@  G"<  !,              ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q0
M2P$"% ,4    "  40%E23XL>"S8$   S$   &               @($."
M>&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ %$!94H.II0/4
M 0  ,@8   T              ( !>@P  'AL+W-T>6QE<RYX;6Q02P$"% ,4
M    "  40%E2EXJ[',     3 @  "P              @ %Y#@  7W)E;',O
M+G)E;'-02P$"% ,4    "  40%E2JL0B%C,!   B @  #P
M@ %B#P  >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ %$!94B0>FZ*M
M^ $  !H              ( !PA   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR
M96QS4$L! A0#%     @ %$!94F60>9(9 0  SP,  !,              ( !
MIQ$  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  \1(

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="goss-20210225.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.gossamerbio.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="goss-20210225.htm">goss-20210225.htm</File>
    <File>goss-20210225.xsd</File>
    <File>goss-20210225_cal.xml</File>
    <File>goss-20210225_def.xml</File>
    <File>goss-20210225_lab.xml</File>
    <File>goss-20210225_pre.xml</File>
    <File>goss-20210225xexx991.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "goss-20210225.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "calculationLink": {
     "local": [
      "goss-20210225_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "goss-20210225_def.xml"
     ]
    },
    "inline": {
     "local": [
      "goss-20210225.htm"
     ]
    },
    "labelLink": {
     "local": [
      "goss-20210225_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "goss-20210225_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "goss-20210225.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 24,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "goss",
   "nsuri": "http://www.gossamerbio.com/20210225",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20210225.htm",
      "contextRef": "i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.gossamerbio.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "goss-20210225.htm",
      "contextRef": "i12cbfcafe9fd4fed9462f5ccf97c0bd6_D20201109-20201109",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.gossamerbio.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001728117-21-000015-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001728117-21-000015-xbrl.zip
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MTC7=)(;C*?!0V)>!8<O$P+C\OG1C/)]^>#, @-RSI.*$8<#IR*.!$*GK@3\
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MQBG%DJ)Q+ Z'5B2'&(I45@RJJ@0KT.T/^_(WDO<;WG<P9A>0925@^7<BGGL
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M^6L/5[]_NFZ_GYW SK ]W&>#)U!+ P04    "  40%E2C6OW$H,!  #, @
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M0%I- \UY+)B"F*L1C2 -I8R'')I)S6)&1QG_=<&9D&<#>=;[#5!+ P04
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ML*,=M(U9]T%V.^APP#8F5,&U>51[6%>G.9Z.N/UN8TXEYT'(0@2PBNP7@4-
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MWIOKC; # UV?U#;)#>.Z(OP^GJW^NH6(0@UEQ$ 4& 4PC2"@#!E@5W4=0C]
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M^#6.//?#_P-02P$"% ,4    "  40%E29&8 Z7 5  "8H0  $0
M    @ $     9V]S<RTR,#(Q,#(R-2YH=&U02P$"% ,4    "  40%E2AC<-
M[8<"  " "0  $0              @ &?%0  9V]S<RTR,#(Q,#(R-2YX<V10
M2P$"% ,4    "  40%E2C6OW$H,!  #, @  %0              @ %5&
M9V]S<RTR,#(Q,#(R-5]C86PN>&UL4$L! A0#%     @ %$!94O&._@,' @
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L<W,M,C R,3 R,C5X97AX.3DQ+FAT;5!+!08     !P ' - !  "A2      !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
